Registry of Lobbyists
Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Budget, Economic Development, Health, Research and Development, Science and Technology, Taxation and Finance
|
Funding for BioCanRx’s Immunotherapy Network in Budget 2023, and continued funding for BioCanRx from various government funding opportunities
|
Grant, Contribution or Other Financial Benefit
|
End date of the last completed financial year: 2024-03-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Innovation, Science and Economic Development Canada (ISED) | $0.00 | Yes |
Address:
Box 611, 501 Smyth Road
Ottawa, ON K1H 8L6
Canada
Telephone number:
613-739-6202
Web address:
https://biocanrx.com/
Stephanie Michaud, President and CEO
BioCanRx is not a subsidiary of any other parent companies.
BioCanRx is not a coalition.
The activities of BioCanRx are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
BioCanRx does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Ujwal Ganguly | No public offices held
Firm: Temple Scott Associates Inc.